Biotech
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 12/19/12 -- ChemDiv, Inc., a fully integrated drug discovery and development contract research organization with research facilities in San Diego, USA and Moscow, Rus ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 12/19/12 -- IBEX Technologies Inc. (TSX VENTURE: IBT) today reported its financial results for the quarter ended October 31, 2012."We are pleased to start th ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 12/19/12 -- Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) has today announced that the Company has been featured on the cover of the p ...
MARSEILLES, FRANCE: A Phase I Study of the Anti-KIR Antibody IPH2102/BMS-986015 in Combination With Ipilimumab in Patients With Selected Advanced Solid Tumors Published on ClinicalTrials.gov ...
CHICAGO, IL: CHICAGO, IL -- (Marketwire) -- 12/18/12 -- Abbott Laboratories continues to advance its capabilities to meet the life science industry's expanding need for more efficient services for solid-dos ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 12/18/12 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the Company") is pleased to announce that it has executed a letter of renewal with Agricul ...
WALTHAM, MA: WALTHAM, MA -- (Marketwire) -- 12/18/12 -- EyeGate Pharma, a privately held specialty pharmaceutical company developing a non-invasive ocular drug delivery platform and ocular therapeutics, announces ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 12/18/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...
SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 12/18/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the last moments of 2012 run their course, it is a good time to take a l ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 12/17/12 -- Paladin Labs Inc. (TSX: PLB) a leading Canadian specialty pharmaceutical company, today announced that Health Canada has approved Silenor® (doxepin h ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 12/17/12 -- Immunovative, Inc. (OTCQB: IMUN) ("The Company") had previously announced that the Company had been invited to present at the Deal Flow Conferenc ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 12/17/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 12/17/12 -- Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) announces today that Immunovative Therapies, Ltd. ("ITL") has regi ...
SOUTH SAN FRANCISCO, CA: Titan Receives $15.75 Million Up-Front Payment, up to $215 Million in Potential Milestones Plus Tiered Royalties; Titan to Host Conference Call Today at 4:05pm ET ...
PISCATAWAY, NJ: Suspending Clinical Development With Goal to Maximize Value Returned to Shareholders ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 12/14/12 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today a ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 12/14/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to tr ...
TUSTIN, CA: Company Expects 20% Growth in Contract Manufacturing Revenue to Over $18 Million for Current Fiscal Year; Back-Log for Future Manufacturing Services Currently Exceeds $30 Million Covering Services to ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 12/13/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) today announced that it has priced an underwritten public offering of an aggregate of 4,950,495 shares of its co ...
